Our 2024 Audience | Kisaco Research

Our 2024 Audience

Life Sciences Strategy Summit on IP & Exclusivity
7-8 October, 2025
Munich, Germany

The Number 1 Forum for Life Science IP and Regulatory Professionals

This industry premier life science legal event will gather the leading pharmaceutical and biotech professionals for 3 days of practical discussion on the protection of pharmaceutical drugs based on patent and regulatory exclusivities.

Attend this face-to-face industry summit and have candid discussions with the European life science intellectual property and regulatory experts. The event allows you to form commercially important business relationships, whilst forming a life science legal strategy for 2024 and beyond.

Once again, this year’s summit will host the pre-event SPC & PTE Forum 2024, allowing a mixed audience of in-house counsels, private practice members and key regulators to discuss the strategies and updates concerning SPCs and PTEs. Add this to your registration and form a comprehensive exclusivity strategy for 2024. 

DOWNLOAD THE 2024 EVENT AGENDA TODAY 

Highlights for 2024 Include

  1. A review of the latest decisions regarding the SPC waiver and its impact upon your generic and innovator life science exclusivity strategy.
  2. Discover the intersection between regulatory and IP law with industry-led sessions on: clinical trials, data exclusivity, a Tecfidera case law review and the Pharmaceutical Strategy for Europe.
  3. Understand the requirements for patentability within the life sciences industry with panel sessions on patent quality, G2/21, enablement and the PTAB.
  4. Discuss the ways in which the UPC is impacting your life science strategy with an industry-led session and judges panel. 

Which In-House Companies Are Attending This October?

Job Titles Include: Assistant Director, Patent Litigation, Associate General Patent Counsel, Deputy General Counsel, Global Head of Intellectual Property Litigation,  Director - Group Patents Legal IP, Director- Dispute Resolution, Director IP,  Dutch and European Patent Attorney, European Patent Attorney Director, Intellectual Property,  Expert Patent Attorney, General Counsel, Board Member,  General Manager – Global Intellectual Property, Global Head of IP, Global Head of IP Litigation, Group Head-IP,  Head of HP Patent Strategies, Head of IP, Head of IP & European Patent Attorney,  Head of Legal, Head of Patent Examination, Head of Patent Section, Head of Patents- Pharma and Consumer Health, Head Patent Department, Head Patent Litigation, Head, IP – Europe, Intellectual Property Director, IP & Information Specialist,  IP Counsel,  IP Expert, European Patent Attorney, IP Manager, Lead IP Litigation Counsel, EMENA,  Lead Patent Counsel, Manager & Head of Patents, Patent Attorney, Patent Counsel Lead Development & Patent Portfolio, Patent Examiner, Patent Law Director, Patent Manager,  Principal Patent Attorney, Senior Counsel, Senior Counsel – Patent Litigation, Senior Counsel European IP and Regulatory Litigation, Senior Counsel- Intellectual Property & Litigation Law, Senior Counsel, Digital and Device Intellectual Property,  Senior Director Intellectual Property, Senior IP Counsel - European Patent Attorney, Senior IP Counsel, Litigation, Senior Legal Counsel, Senior Litigation Counsel, Senior Patent Attorney,  Senior Patent Counsel,  Senior Patent Manager Patent Litigation, Sr. Director Legal, IP & Product Portfolio, SVP IP,  Vice President and Head of Legal & Intellectual Property, Vice President IP

250+
Attendees
65+
Industry - Leading Speakers
15+
Hours Of Networking
10+
Round Tables
26+
Different Countries

Which Law Firms, Consultant Firms and Service Providers Will Be Attending This October?

Our 2024 Sponsors

Based on your objectives, we can create bespoke packages for you. From presenting your expertise on stage to partnering with us to deliver networking activities. Partner with us in 2024 to showcase your brand and make valuable new connections. Opportunities include thought leadership, branding, and networking.

Discuss your objectives with Duncan Henderson, Commercial Partnerships Director, [email protected]

PARTNER WITH US